Simplexia
Blood & Organ Banks · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Medicinaregatan 8a, Goeteborg, Vaestra G...Website
www.simplexia.seRevenue
<$5 MillionIndustry
ZI Rank: 1
About Simplexia
Simplexia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Simplexia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Simplexia has new funding data
Congratulate Masked Content for being promoted to Masked Content at Simplexia
Check out if Simplexia is spiking on competitors!
Check if Simplexia has recently received funding, and reach out quickly before it becomes old news!
Simplexia, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Simplexia had a recent Job posting/layoffs
Earning: See what the market has to say on Simplexia recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Simplexia launches new products
Recommended Actions
Find VP level buyers at Simplexia
Find 2 more new buyers
Simplexia Tech Stack
A closer look at the technologies used by Simplexia
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Simplexia
Simplexia is a biotechnology company focused on developing a novel vaccine for genital herpes, based on groundbreaking research from the University of Gothenburg. Their unique approach targets the HSV-2 virus, which affects over 400 million people globally, by utilizing a specific protein that is unique to HSV-2. The company aims to provide a long-... Read More
